NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Pearl Bio

Pearl Bio

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.pearlbio.com/

Last Round

Series A

Mar 12, 2024

Total Funding Raised

$4.38M

Company Overview

Pearl Bio is a biotechnology company that has developed a synthetic biology platform to create biomaterials for smart biologics by using proprietary technology that couples genome and ribosome engineering.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Advanced Materials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

synthetic biologygenomically recoded organismsGROsprogrammable biologicsprotein engineeringnon-standard amino acidstethered ribosomesdrug discoverybiomaterialsbiotech platformsmart biologicsprotein designdesigner proteinssynthetic genomicsbio-pharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pearl Bio Comparables

Compare Pearl Bio with similar companies based on industry and business-model similarity.

Pearl Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
GRO Biosciences
92%
Tektonyx Bio, Inc.
85%
Constructive Bio
82%

Pearl Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 12, 2024
GrantAug 1, 2023
SeedOct 7, 2021

Key People

Founding team and executive leadership

Amy Cayne Schwartz

Co-Founder, Chief Operating Officer And Chief Business Officer GC

Founding Team

Pearl Bio Investors

Notable investors and investment history

Pearl Bio investors
InvestorRounds
The EngineSeed
Khosla VenturesSeed
National Science FoundationSeed, Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 12, 2024

    Completed a Series A funding round.

Pearl Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Pearl Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pearl Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range11
Year Founded2020
Last FundingMar 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.